Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Teva Pharma shares up after positive results from migraine drug trial: Tirrell

CNBC's Meg Tirrell joins "Closing Bell" to discuss which pharmaceutical companies could be impacted by ongoing lawsuits surrounding the opioid…

Teva Launches Generic Version of Mylans EpiPen for KIds

Teva (TEVA) launches generic version of Mylans (MYL) popular EpiPen Jr allergy treatment at a price of $300 for a…

Teva Rises on Positive Test Results for Migraine Treatment

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Migraine drug trial results boost Teva

The FOCUS Phase IIIb trial results published by The Lancet" demonstrate that Ajovy significantly relieves migraines....…

Shares of Teva up 3% on positive migraine trial

Shares of Teva Pharmaceutical Industries rose 3% in premarket trade Wednesday after The Lancet published results from a late-stage…

Endo Ohio opioid settlement boosts Teva on NYSE

The $11 million being paid by Endo is considered a modest amount and could mean Tevas liability on opioid suits…

SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders of Class Action and Lead Plaintiff Deadline: August 20, 2019

NEW YORK , Aug. 20, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &…

UBS cuts Tevas price target again

UBS gives two scenarios for Tevas share: an upside, in which the target price reaches $17, and a downside in…

Tevas Generic EpiPen Jr Is Now Available for $300

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva to launch generic version of EpiPen for young children

Teva Pharmaceutical Industries Ltd said on Tuesday its generic version of Mylans EpiPen for young children will be available in most retail pharmacies…

Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack

Teva Pharmaceutical Industries Ltd. said Tuesday its FDA-approved generic version of the EpiPen is available in the U.S. at…

Starkes Wachstum, höhere Verluste - Herr Feltens wie "Shop-Apotheken Sie das weg"-

Ratiopharm hatte auch was für die Shop Apotheke: Der neue CEO Stefan Feltens war früher u. a. bei Höchst, Teva…

TEVA Pharmaceutical-Aktie verliert weiter an Boden! - Aktienanalyse

Zürich (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse des Analysten Navin Jacob von der UBS: Laut einer Aktienanalyse vertritt Navin Jacob, Analyst bei der…

Wix market cap overtakes Teva

Although Tevas share price rose 4.06% on Wall Street on Friday, the Israeli pharmaceutical companys market cap still finished the…

Should Value Investors Pick Teva Pharmaceutical (TEVA) Now-

Lets see if Teva Pharmaceutical (TEVA) stock is a good choice for value-oriented investors right now from multiple angles....…

Ratiopharm-Mutter Teva im Sonderangebot - oder täuscht der Eindruck-

In den zurückliegenden drei Jahren hat der Kurs der Teva-Aktie knapp 90 Prozent an Wert verloren. Der einstige aufstrebende Generika-Star…

Warren Buffetts huge losses on Teva mount

Berkshire Hathaway has kept its 4% stake in the Israeli pharmaceutical company, costing it hundreds of millions of dollars on…

US Congress heaps more misery on Teva

Teva fell over 10% on a bearish Wall Street after Congress members accused it of obstructing a price-fixing probe and…

Tevas stock tumbles toward 20-year low; Moodys turns negative on drugmakers junk-rated debt

Shares of Teva Pharmaceutical Industries Ltd. tumbled 9.7% toward a 20-year low, after Moody's Investors Service revised its outlook…

UPDATE 3-U.S. lawmakers push Mylan, Teva over drug pricing probe

The head of the U.S. House of Representatives oversight panel on Wednesday called on three drugmakers to turn over documents as part…

UPDATE 2-U.S. lawmakers push Mylan, Teva over drug pricing probe -statement

The head of the U.S. House of Representatives oversight panel on Wednesday called on three drugmakers to turn over documents as part…

Teva plunges again as Moodys revises outlook to negative

Moodys is concerned about Tevas debt and refinancing needs, Copaxone sales erosion, weak uptake of new drugs, and litigation risks....…

UPDATE 1-U.S. lawmakers push Mylan, Teva over drug pricing probe -statement

The head of the U.S. House of Representatives oversight panel on Wednesday called on three drugmakers to turn over documents as part…

U.S. lawmakers push Mylan, Teva over drug pricing probe -statement

The head of the U.S. House of Representatives oversight panel on Wednesday called on three drugmakers to turn over documents as part…

Teva: Maximum Pessimism

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Landa: I see Teva being broken up

Benny Landa, who sold off his Teva holding two years ago, traces the companys troubles to the "idiotic" firing of…

TEVA Pharmaceutical: Lage stabilisiert sich! - Aktienanalyse

Atlanta (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Analyst Gregg Gilbert von SunTrust Robinson Humphrey: Laut einer Aktienanalyse empfiehlt Gregg Gilbert, Analyst von…

TEVA Pharmaceutical-Aktie: Wo ist der Boden- - Aktienanalyse

St. Petersburg (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Analyst Elliot Wilbur von Raymond James: Elliot Wilbur, Aktienanalyst von Raymond James, äußert im…

TEVA Pharmaceutical: Anleger sollten mit Einstieg noch warten! - Aktienanalyse

New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse des Analysten Ken Cacciatore von Cowen and Company: Ken Cacciatore, Aktienanalyst von Cowen and Company,…

Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q2 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Industries Limited (TEVA) Q2 2019 Earnings Call Transcript

TEVA earnings call for the period ending June 30, 2019....…

Opioid Risk Smothers Drug Stocks

Fears of massive legal settlements for drug companies such as Teva will keep a lid on stock prices....…

UPDATE 2-Israels Teva Pharm profit falls less than expected, CFO to leave

* Migraine drug Ajovy Q2 sales reach $23 mln (Adds CEO comments from conference call, interview)...…

Teva (TEVA) Beats Q2 Earnings & Sales Estimates, Shares Rise

Teva Pharmaceutical (TEVA) posts better-than-expected results. Shares rise in pre-market trading....…

Teva Stock Dives Despite a Better-Than-Expected Earnings Report

Shares of Teva Pharmaceutical Industries dived on Wednesday morning, even though the company reported quarterly earnings that beat Wall Street…

Thinking about buying stock in Aurora Cannabis, Beyond Meat, CVS Health, Teva Pharmaceutical, or Uber-

NEW YORK , Aug. 7, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB,…

Teva Pharmaceutical Industries Limited 2019 Q2 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Reports Q2 Earnings Beat, Reaffirms Guidance

Teva Pharmaceutical Indus (NYSE: TEVA) reported second-quarter earnings of 60 cents per share, which beat the analyst consensus estimate of…

UPDATE 1-Israels Teva Pharm profit falls less than expected

Teva Pharmaceutical Industries reported a smaller-than-expected drop in second-quarter profit on Wednesday and said its chief financial officer was leaving the company....…

Teva beats analysts on Q2 profit as CFO quits

The Israeli pharmaceutical companys profit fell less than expected. CFO Michael McClellan announced he is stepping down....…

Tevas stock jumps off 20-year low after earnings beat expectations; CFO to step down

Shares of Teva Pharmaceutical Industries Ltd. jumped 4.1% in premarket trading Wednesday, after the branded and generic drugmaker reported…

Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance, as US Generic Launches Rise

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Israels Teva Pharm Q2 profit falls less than expected

Israel-based Teva Pharmaceutical Industries reported a smaller-than-expected drop in second-quarter profit on Wednesday and reaffirmed its full year outlook....…

Teva tanks on renewed opioid settlement concerns

A reported settlement by large US distribution companies for fueling the opioid epidemic has ignited fears that Teva will have…

Why Chesapeake Energy, Teva Pharmaceutical Industries, and GreenSky Slumped Today

Despite a nice bounce for the market, these stocks didnt join in the rally....…

Heres Whats Pushing Teva Pharmaceutical Industries Stock Even Lower Today

A confluence of bad news has sunk the stock to a 20-year low....…

Teva Pharmaceutical Q2 Earnings Preview

Teva Pharmaceutical Indus (NYSE: TEVA) will be releasing its next round of earnings this Wednesday, August 7. For all of…

Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect

Teva Pharmaceuticals Industries is expected to report declining second-quarter earnings on Wednesday — and it doesn’t seem like the downward…

Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings-

Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Tevas (TEVA) sales…

Teva to sell Oncotest to Rhenium

Oncotest, which provides genetic testing services prior to cancer treatment, is worth tens of millions of dollars....…